| Time (months) | FPG (mmol/L) | A1C (%) | ||
Group A (n = 20) | Group B (n = 19) | Group A (n = 20) | Group B (n = 19) | ||
Control Phase | 0 | 12.23 ± 2.37 | 12.80 ± 2.60 | 8.88 ± 1.35 | 9.41 ± 1.50 |
3 | 2.00 ± 2.32 | 13.87 ± 3.54 | 8.38 ± 1.24 | 9.35 ± 1.86 | |
Treatment Phase | 5 | 11.56 ± 2.59 | 12.53 ± 4.06 | 9.58 ± 1.94 | 9.93 ± 2.25 |
7 | 11.79 ± 2.49 | 12.41 ± 3.25 | 9.39 ± 1.69 | 10.01 ± 2.13 | |
9 | 11.88 ± 2.50 | 12.13 ± 2.70 | 8.94 ± 2.04 | 9.21 ± 3.18 | |
11 | 12.69 ± 2.55 | 12.97 ± 3.21 | 9.36 ± 1.75 | 9.51 ± 1.79 | |
13 | 12.83 ± 2.59 | 13.01 ± 3.14 | 9.26 ± 2.19 | 9.57 ± 1.89 | |
Two-way ANOVA | p < 0.001 | NS | p < 0.05 | NS |